Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance.
about
Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in Staphylococci: a CLSI collaborative study.Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolatesLow prevalence of methicillin resistant Staphylococcus aureus as determined by an automated identification system in two private hospitals in Nairobi, Kenya: a cross sectional studyEvaluation of the automated Vitek 2 system for detection of various mechanisms of macrolide and lincosamide resistance in Staphylococcus aureus.Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).Clindamycin Resistance among Staphylococcus Aureus Isolated at Mbarara Regional Referral Hospital, in South Western UgandaDefining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient.Use of a DNA microarray for simultaneous detection of antibiotic resistance genes among staphylococcal clinical isolates.Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes.The prevalence of inducible clindamycin resistance among staphylococci in a tertiary care hospital - a study from the garhwal hills of uttarakhand, IndiaModes and modulations of antibiotic resistance gene expression.Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 System: comparison with results obtained with the Vitek-2 and Phoenix systemsPrevalence of inducible clindamycin resistance in staphylococcal isolates at a Korean tertiary care hospital.Prevalence of methicillin-resistant and methicillin-susceptible s. aureus in the saliva of health professionals.Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing.A Low Prevalence of Inducible Macrolide, Lincosamide, and Streptogramin B Resistance Phenotype among Methicillin-Susceptible Staphylococcus aureus Isolated from Malaysian Patients and Healthy Individuals.Antimicrobial susceptibility testing: a primer for clinicians.Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci.Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital.Multiple-locus VNTR Analyses of Methicillin-resistant Staphylococcus aureus from Jamaica.Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp.Inducible Clindamycin Resistance in Methicillin-Resistant and-Susceptible Staphylococcus aureus Isolated From South East of Iran.Inducible Clindamycin Resistance among Staphylococci Isolated from Burn Patients.Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp.Prevalence of inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples.Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus.Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLSB) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran.Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp.Emergence of methicillin-resistant Staphylococcus aureus ST239 with high-level mupirocin and inducible clindamycin resistance in a tertiary care center in Chennai, South IndiaInducible Clindamycin Resistance in Staphylococcus aureus Isolated from Clinical Samples.Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure.Agar dilution method for detection of inducible clindamycin resistance in Staphylococcus spp.The prevalence of inducible and constitutive clindamycin resistance among the nasal isolates of staphylococci.Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro.Clinically overt infections with methicillin-resistant Staphylococcus aureus in animals in New Zealand: a pilot study.
P2860
Q33856412-2D1228E9-E609-44D1-BA8E-56401BEB6A68Q34498620-B6162DFE-729A-4F88-8B22-FE18B9F10566Q34719746-EE386ED9-2418-473F-AC77-5E8B4C12F66CQ34728453-EE8815CF-D5CC-4F5F-B7FC-E245A6B5F798Q35036119-B90CBCC8-1054-4D63-A1BC-BB1F6D3BB78BQ35662677-8FFF2199-2953-43BB-B41A-8AE80CF6CFA9Q35671413-11E69CF7-A204-4B10-8D20-81A3F8F5E4DFQ36161246-BDF63E03-B0E2-4B85-9FFC-9C24C0812EFCQ36314481-2B58DF68-E732-4D47-AC8A-2A48A24EA745Q36452596-B42567B8-8C35-4029-BE3B-D3E06002F1A4Q36622487-830A6AC9-9E76-4EED-AB46-2D8942EA4A62Q36708242-811EE8FC-978D-401F-B06C-4E2B39F4B664Q36891669-DF5BDC78-3D08-4A07-AE26-E79B22DF13F9Q37205609-22FF0622-ABA7-4044-901A-DEA88BA02545Q37222757-94DC4BA2-A321-4C95-B3FD-E7FD91D96EE7Q37421099-FF8F6486-5CC5-41E5-AB17-174C86878972Q37471019-D293A688-1F16-4645-98C0-1220194CC072Q37621552-2B657F88-E0C8-4683-B0C1-6903B1057C8AQ40133451-98784EFD-B78C-4C7B-8A80-171CA9EA6A03Q40938285-62F5BF35-2375-47E4-9F2D-FC169127EA35Q40961288-D5370E55-862E-47B7-81C2-24D3BFCA5D6AQ41068259-BBD77DA7-834F-4019-8902-1A14A5017CCEQ41449187-C892EAA6-6827-499B-A4E0-CDC8EAB03CB4Q41836878-57420612-896B-47E4-AE8C-69DE26833DA3Q41908540-D4484114-E1B7-4624-A1B8-C9F41903D4A6Q42122623-49C54D6D-200F-43EB-ADC7-3E8026D6F948Q42264787-F1819126-DD53-4971-BFC1-309E7246B9FFQ42415273-DA9688E1-D65D-43BC-8229-746A5274E6CCQ42588823-705496B3-DCA0-4C84-896C-BCD25A3E18B4Q42691892-5BE27C37-9F5B-4623-A150-EDACD485C62DQ42763548-ADDE8DFB-2BC4-41C8-942B-854466CB270EQ42845017-6228640B-5F82-4D69-945D-8AB80E3037F0Q42910041-6BC80928-6904-477F-A1AD-D4DF4ADA9E8CQ42968827-5EDA5EA8-5BDC-419A-8052-292B2E70B8BEQ44616846-2DD66A91-9CB0-47F2-8E9B-78556BEC84D7Q46330858-A10AB110-31F2-48C2-98C3-5A696B8C9BB2
P2860
Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Clindamycin treatment of Staph ...... ucible clindamycin resistance.
@en
Clindamycin treatment of Staph ...... ucible clindamycin resistance.
@nl
type
label
Clindamycin treatment of Staph ...... ucible clindamycin resistance.
@en
Clindamycin treatment of Staph ...... ucible clindamycin resistance.
@nl
prefLabel
Clindamycin treatment of Staph ...... ucible clindamycin resistance.
@en
Clindamycin treatment of Staph ...... ucible clindamycin resistance.
@nl
P2093
P356
P1476
Clindamycin treatment of Staph ...... ucible clindamycin resistance.
@en
P2093
Drinkovic D
Ellis-Pegler R
Holland DJ
P304
P356
10.1093/JAC/48.2.315
P407
P577
2001-08-01T00:00:00Z